Form 4: Emergent BioSolutions Director Neal Franklin Fowler Sells 35,000 Shares
SEC Form 4 Filing
Director Neal Franklin Fowler of Emergent BioSolutions Inc. sold 35,000 shares of common stock on March 12, 2025, at a weighted average price of $5.83.
Summary
- On March 12, 2025, Neal Franklin Fowler, a director of Emergent BioSolutions Inc., sold 35,000 shares of the company's common stock.
- The sale was executed at a weighted average price of $5.83 per share.
- Following the transaction, Mr. Fowler directly owns 101,100 shares of Emergent BioSolutions Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. A director selling shares doesn't inherently indicate positive or negative sentiment, but it could be interpreted differently depending on the context and the size of the sale relative to their holdings.
Industry Context
This Form 4 filing is a routine disclosure of a transaction by a company insider. It provides transparency to the market regarding the trading activities of individuals with access to non-public information.
Stakeholder Impact
- The sale of shares by a director could potentially influence investor sentiment, although the impact is likely to be minimal given the size of the transaction relative to the company's overall market capitalization.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of transaction: Neal Franklin Fowler sold 35,000 shares of Emergent BioSolutions Inc. common stock. |
| 03/12/2025 | Date of signature: Richard S. Lindahl, Attorney-in-fact, signed the document. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.